NCT04412070View on ClinicalTrials.gov

Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients

Active, not recruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions

Bladder Cancer

Trial Locations (1)

92151

Foch hospital, Suresnes

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Hopital Foch

OTHER